AzTrials
AzTrials

Palliative CareDTalkNCT01883375

Dignity Talk: Helping Palliative Care Patients and Families Have Important Conversations

A study testing Dignity Talk and The Dignity Talk Communication Topics in people with Palliative Care and Family, run by University of Manitoba at 13 sites in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Dying patients and their families face many challenges near the end-of-life. Not only do patients often experience physical distress, but they also have feelings of loss of dignity, isolation, and uncertainty. Family members also face many challenges. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Palliative Care, Family, End of Life Care
What is being tested?
Dignity Talk and The Dignity Talk Communication Topics
Could I receive a placebo?
No, everyone receives an active treatment
How many people
56 participants
Where
13 sitesCanada
Study dates
Mar 2013to 31 Oct 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • For Patient:
  • Patients being cared for:
  • in a palliative care unit or whose care is focused on palliation as determined by clinical staff
  • or patients who have have a confirmed diagnosis of amyotropic lateral sclerosis, and have symptoms in a domain that interferes with their social or occupation functioning: a) mobility, b) dysphasia, c) dyspnea, or d) speech or patients who have are have been on dialysis > 3 months and are > 60 years of age - or residents of Personal Care Home all of whom are:
  • 18 years of age or older
  • able to provide informed oral and written consent
Show all 15Show fewer
  • cognitive capacity (based on clinical consensus)
  • For Family Member or Close Friend:
  • Family member or close friend who the patient identifies they would be comfortable talking with using the Dignity Talk question framework
  • Family member who is 18 years of age or older
  • Family member who is able to provide oral and written consent
  • Family member who has cognitive capacity to participate in meaningful conversation (based on research staff decision)
  • For Healthcare Provider:
  • Employed one of the participating sites
  • in a discipline directly involved in clinical care (physician, nursing, social work, spiritual care, allied healthcare, etc.)

Who cannot join

  • not meeting the above inclusion criteria

Trial locations and contacts

13 sites in 1 country.

13 sites in 1 country

Canada13 sites
  • Dr. Bob Kemp Hospice

    Hamilton, Ontario, L9B 1B1

  • Victoria Hospice

    Victoria, British Columbia

  • St. Boniface Hospital

    Winnipeg, Manitoba, R3E 0V9

  • Riverview Health Centre

    Winnipeg, Manitoba, R3L 2P4

  • Concordia Hospital

    Winnipeg, Manitoba

  • Deer Lodge Centre

    Winnipeg, Manitoba

  • Grace Hospital

    Winnipeg, Manitoba

  • Health Sciences Centre

    Winnipeg, Manitoba

  • Manitoba Renal Program

    Winnipeg, Manitoba

  • Seven Oaks Hospital

    Winnipeg, Manitoba

  • Victoria Hospital

    Winnipeg, Manitoba

  • Winnipeg Regional Health Authority

    Winnipeg, Manitoba

  • WRHA Personal Care Homes

    Winnipeg, Manitoba

Other trials in Canada

About this study

Official title: Dignity Talk: a Novel Palliative Care Intervention for Patients and Their Families

Dying patients and their families face many challenges near the end-of-life. Not only do patients often experience physical distress, but they also have feelings of loss of dignity, isolation, and uncertainty. Family members also face many challenges. They bear witness to the suffering of loved ones, and they face uncertainty, loss, and at times a mounting sense of helplessness.

The purpose of this study is to introduce and evaluate a new intervention called Dignity Talk, meant to enhance end-of-life experience for both patients and their families. Dignity Talk is based on a set of questions by which terminally ill patients and their family members can engage in meaningful conversations with each other. It is intended to lessen feelings of loss and helplessness and enhance feelings of connectedness by facilitating conversations that tap into a sense of meaning and purpose, sharing of memories, wishes, hopes, and giving guidance to those who will soon be left behind.

Read more

In Phase 1, 20 patients and family members will help finalize the method and Dignity Talk question framework (is it easy to understand, do the investigators have the right questions, and is the wording sensitive). In Phase 2 of the study the investigators will ask 100 patient-family pairs for feedback about Dignity Talk: what influence it had on their palliative care experience, whether it works well, and whether this intervention should become a regular part of palliative care. The investigators will also ask for feedback from health-care providers in both phases. We are requesting approval for an amendment to the healthcare provider feedback focus group questions. Will add those documents when they are approved.

Four to six months after the death of their loved one, the investigators will contact the family member to ask their thoughts about Dignity Talk, how it shaped their experience of their grief and bereavement.

The investigators expect that the study will show that Dignity Talk can be an effective, highly accessible palliative care intervention, which will enhance the end-of-life experience for palliative patients and the families who support them.

Read the detailed description

See above summary

Being tested
Dignity Talk, The Dignity Talk Communication Topics
Keywords
Palliative Care, Family, adaptation, psychological

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dignity TalkBehavioural

    Patient and family member participants will be given the Dignity Talk framework questions and asked to use them in conversation with each other. Research nurse will return at day 4-6 to confirm both participants have covered all items they wish to discuss. 4-6 months after the death of patient, family members will be contacted in order to collect data pertaining to their bereavement experiences and distress. Will also be asked to complete evaluative feedback on Dignity Talk.

  • The Dignity Talk Communication TopicsBehavioural

    There have not been any non-completers - this arm not being used currently

Study groups in NCT01883375
Study groupRoleWhat they receive
Dignity Talk dyad completersExperimentalThose dyads where both patient and family member co-participant complete the protocol using the Dignity Talk Communication Topics
Receives: Behavioral: Dignity Talk
Dignity Talk non-completersExperimentalThose dyads where patient and family member co-participant either do not complete the protocol or do not use the Dignity Talk Communication Topics (November 2016 - the investigators have not as yet enrolled any participants who have not completed the study without using the Dignity Talk Topics. However some participants have withdrawn from the study without completing.
Receives: Behavioral: The Dignity Talk Communication Topics

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Family communication connectedness Index

    Measured: 31 months

Secondary outcomes (1)
  1. Number of Participants with Adverse Events as a Measure of Safety and Tolerability

    Measured: 31 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jun 2013 (estimated)
  2. Study startMar 2013
  3. Primary completion30 Sep 2017
  4. Study completion31 Oct 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
56 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01883375
Sponsor's protocol ID
H2013:024
Acronym
DTalk
Status last verified
Nov 2016
First submitted
11 Feb 2013
Last updated
14 Dec 2017
Results posted
No
Data monitoring committee
No

Publications

  • Guo Q, Chochinov HM, McClement S, Thompson G, Hack T. Development and evaluation of the Dignity Talk question framework for palliative patients and their families: A mixed-methods study. Palliat Med. 2018 Jan;32(1):195-205. doi: 10.1177/0269216317734696. Epub 2017 Nov 13.

    PubMed 29130367

Questions about this trial

What is this clinical trial studying?

A study testing Dignity Talk and The Dignity Talk Communication Topics in people with Palliative Care and Family, run by University of Manitoba at 13 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 15 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Dec 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 13 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Family communication connectedness Index (time frame: 31 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01883375, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Dec 2017; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in